Professional Documents
Culture Documents
Vadilal Valuation
Vadilal Valuation
PV
NPV 4424.9
Actual 4441.76
Risk-free Rate 1.51%
MMRP 4.240%
1 2 3 4 5
188.48 210.80 220.00 227.70 232.25
0.33 0.12 0.04 0.04 0.02
1026.59 1071.39 1108.89 1131.07 1145.32
0.21 0.21 0.21 0.21 0.21
0.58 0.21 0.17 0.10 0.06
79.78 166.00 182.50 205.52 218.00
4916.47
79.78 166.00 182.50 205.52 5134.47
75.44 148.44 154.32 164.34 3882.34
0.01
220.75
Vadilal Industries
In Rs. Crores
Export Revenue 250
Domestic Revenue 106.54
Total Revenue 356.54
Americas 50
Europe 50
Middle East 50
South East Asia 50
Australasia 50
India 106.54
Vadilal Enterprise
CRP
CRP (Source:
% of revenues domestically Aswanth
by avg firm Lambda Damodaran Sheet)
81.90% 122.100% 1.85%
CRP
4.236%
2.25885226%
Cost of Equity
Risk Free Rate 4.33%
Mature market risk premium 4.24%
CRP 4.236%
Beta 0.91
Cost of Equity 12.421929483%
Cost of Debt
Rating As per CARE BBB-
Risk free rate (Rfr) 4.33%
Country Default spread 1.28%
Company Default Spread 2.97%
Cost of Debt 8.58%
Tax Rate 30%
After tax Cost of Debt 6.004600%
WACC
Debt 14,119.00
M-Cap of Equity (in lacs) 66476
Debt/Equity 21.24%
Weight of debt 17.52%
Weight of Equity 82.48%
WACC 11.30%
Rf Calculation
10 year Bond Rate for India 6.31%
Default Spread 1.98%
Rf Calculation 4.33%
Cost of Equity
Risk Free Rate 4.33%
Mature market risk premium 4.240%
Beta 0.58
CRP 2.26%
Cost of Equity 9.0481%
Cost of Debt
Rating As per CARE BBB-
Risk free rate (Rfr) 4.33%
Country Default spread 1.28%
Company Default Spread 2.97%
Cost of Debt 8.58%
Tax Rate 30%
After tax Cost of Debt 6.00600%
WACC
Debt 1,196.00
M-Cap of Equity (in lacs) 14039
Debt/Equity 8.52%
Weight of debt 7.85%
Weight of Equity 92.15%
WACC 8.81%
STANDALONE STATEMENT OF PROFIT AND LOSS for the year ended March 31, 2021
Particulars
I Revenue From Operations
% Change
II Other Income
III Total Income (I+II)
IV Expenses:
Cost of Materials Consumed
% of Revenue
Purchase of Stock-in-trade
Changes in Inventories of Finished Goods and Stock-in-trade
Excise Duty on Sale of Goods
Employee Benefits Expense
% of Sales
Finance Costs
% of Borrowings
Depreciation and Amortization Expenses
Depriciation as a Percentage of PPE
Other Expenses
% of Sales
Total Expense (IV)
EBIT
EBIT Margin
V Profit / (Loss) Before Tax (III-IV)
PBT Margin
VI Tax Expenses
(a) Current Tax
Tax Rate
(b) Deferred Tax
Total Tax Expenses
VII Profit / (Loss) for the year (V-VI)
VIII Other Comprehensive Income
(i) Item that will not be reclassified to profit or loss
Remeasurement of defined benefit plans
(ii) Income tax relating to items that will not be reclassified to profit or loss
Other Comprehensive Income for the year
Total Comprehensive Income for the year (VII+VIII)
Earning Per Share (Face Value of ` 10 each)
- Basic & Diluted
Inventory In Days
Debtor in Days
Other Current Assets
Creditors in Days
Other Current Liabilities
Calculations:
Total Borrowings
Growth%
Capex
Depriciation
FCFF Calculation
EBIT(1-t)
Capex
Depriciation
Change in WC
Total Reinvestment
Year
FCFF
Terminal Value
PV of CF and terminal Value
Valuation
Terminal Growth rate
WACC
Value of Operating Assets
Value of Equity
# Shares Outstanding (lakhs)
Year Ended March 31, 2017 Year Ended March 31, 2018 Year Ended March 31, 2019
48438.1 52013.98 50705.76
0.073823704893462 -0.025151315088751
304.24 743.53 1258.46
48742.34 52757.51 51964.22
2021
Year Ended March 31, 2017 Year Ended March 31, 2018 Year Ended March 31, 2019
Year Ended March 31, 2017 Year Ended March 31, 2018 Year Ended March 31, 2019
2677.57 2223.75 4867.61
-250
-2405.47 -2268.77 -3211.66
31.96 18.7 20.74
-1300 -8080
1300 8121.68
14.12
56.95 60.54 72.82
-2302.44 -2439.53 -3076.42
Year Ended March 31, 2017 Year Ended March 31, 2018 Year Ended March 31, 2019
9900.03 12404.26 12307.31
0.252951758732044 -0.00781586325988
2437.43 2287.47 3232.4
0.0641
0.113
71050.1050925289
65512.9950925289
72
909.902709618457
Financial Statements
(` in Lacs)
Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022
51662.97 35654.01 55263.7155
0.018877736967161 -0.309873009623721 0.55
842.08 1202.18 1262.289
52505.05 36856.19 56526.0045
860.43 17.39
0.250209908330831 -0.005484301455444
-636.21 -778.28
224.22 -760.89
3214.77 -2409.82
-35.58 3.27
-2.54 -0.82
-38.12 2.45
3176.65 -2407.37
44.73 -33.53
Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022
298.81 299.31
274.64 1.05
440.83 215.39
141.46 125.6
626.97 253.47
32760.09 31424.48
4820.28 5537.11
738.47 589.33
195.53 256.67
1589.62 815.37
609.25 557.43
7953.15 7755.91
Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022
3438.99 -3170.71
1887.89 1828.62
-1.53 21.22
-24.07 -2.08
-69.42 -85.83
0.21 -0.06
3.63 -0.5
-28.99 -28.91
-55.65 -51.81
-103.87 -414.59
1472.53 2008.52
19.38 -6.63
22.79 24.05
-135.37 32.18
2987.53 3324.18
6426.52 153.47
-2725 1923.58
-578.63 1484.25
2668.6 2634.71
-635.03 6042.54
-1034.55 19.51
4756.94 6215.52
-5160.01 -1435.22
16.37 15.22
24.07 2.08
-12 -
85.33 381.01
-5046.24 -1036.91
4169.71 2417.5
-5597.84 -1922.52
3915.22 -3516.54
-76.22 -85.56
-1430.07 -1889.89
-108.32 -
872.48 -4997.01
583.179999999999 181.6
Year Ended March 31, 2020 Year Ended March 31, 2021 Year Ended March 31, 2022
15299.39 12499.68 15299.39
0.243114051730232 -0.18299487757355
5176.38 1450.44 3565.41666666667
1962.88287061049
3950.32686494745
3565.41666666667
1962.88287061049
314.069827226311
1916.60362328249
1
2033.72324166496
1827.24460167561
Year Ended March 31, 2023 Year Ended March 31, 2024 Year Ended March 31, 2025
59132.175585 63271.42787595 67700.4278272665
0.07 0.07 0.07
1325.40345 1391.6736225 1461.257303625
60457.579035 64663.10149845 69161.6851308915
Year Ended March 31, 2023 Year Ended March 31, 2024 Year Ended March 31, 2025
Year Ended March 31, 2023 Year Ended March 31, 2024 Year Ended March 31, 2025
16064.3595 16867.577475 17710.95634875
0.05 0.05 0.05
3850.65 4158.702 4574.5722
2070.34686621615 2189.73186053985 2321.76863813253
2 3 4
3105.6024935626 4150.86261547523 4712.1021473229
2507.00695090255 3010.59867674842 3070.67631402532
Year Ended March 31, 2026
72439.4577751752
0.07
1534.32016880625
73973.7779439815
39117.3071985946
0.54
1017.654246
6157.35391088989
0.085
2231.5804999425
0.12
2472.83894483604
0.067058801424427
14487.891555035
0.2
65484.7784140995
10720.5800298244
0.147993653722493
8488.99952988194
0.117187507894228
Year Ended March 31, 2026
39434.8711063316
16344.2537713241
1.28
4713.36479503193
846.73
1045.27
257.19
83.28
1587.10085267007
24878.4694190261
11157.9024997125
12888.4163892058
2756.58
17.82
703.031065539401
27523.7499544577
152.506730492625
23.7491859136503
7.99690981981779
120.260629346928
3.54235587624484
7504.40602087711
5032.02942
2472.83894483604
395.231438041868
2954.42191320583
5 6
4549.98410767128 4841.63809
99011.0038644789
60634.578549177
STATEMENT OF PROFIT AND LOSS for the year ended March 3
Particulars
I Revenue From Operations
% Growth
II Other Income
III Total Income (I+II)
IV Expenses:
Purchase of Stock-In-Trade
% of revenue
Changes in Inventories of Stock-In-Trade
Employee Benefits Expenses
% of Sales
Finance Costs
% Of Borrowings
Depreciation and Amortization Expenses
% of PPE
Other Expenses
% Of sales
Total Expense (IV)
V Profit / (Loss) Before Tax (III-IV)
EBIT
EBIT Margin
VI Tax Expenses
(A) Current Tax
(B) Deferred Tax Expenses
(C) Short / (Excess) Provision of Tax of Earlier Years
Total Tax Expenses
VII Profit / (Loss) for the year (V-VI)
VIII Other Comprehensive Income
Item that will not be reclassified to Profit or Loss
- Remeasurement of Defined Benefit Plans
- Tax Expense on Above Items
Other Comprehensive Income for the year
Total Comprehensive Income for the year (VII+VIII)
Earnings per Share (Face value of ` 10 each):
- Basic
- Diluted
BALANCE
Particulars SHEET as at March 31, 2021 Note
No.
I. ASSETS
Non-Current Assets
(a) Property,Plant And Equipment
(b) Capital Work-In-Progress
(c) Other Intangible Assets
(d) Financial Assets
(i) Investments
(ii) Loans
(iii) Other Financial Assets
(e) Deferred Tax Assets (Net)
(f ) Other Non-Current Assets
Total Non-Current Assets
Current Assets
(a) Inventories
(b) Financial Assets
(i) Trade Receivables
(ii) Cash And Cash Equivalents
(iii) Bank Balance Other Than (ii) Above
(iv) Loans
(v) Other Financial Assets
(c) Current Tax Assets (Net)
(d) Other Current Assets
Total Current Assets
TOTAL ASSETS
II. EQUITY AND LIABILITIES
Equity
(a) Equity Share capital
(b) Other Equity
Total Equity
Liabilities
Non-Current Liabilities
(a) Financial Liabilities
(i) Borrowings
(ii) Other Financial Liabilities
(b) Provisions
Total Non-Current Liabilities
Current Liabilities
(a) Financial Liabilities
(i) Borrowings
(ii) Trade Payables
-- total
total outstanding
outstanding dues
dues of
of micro enterprises
creditors and
other than smallenterprises
micro enterprises
and small enterprises
(iii) Other Financial Liabilities
(b) Provisions
(c) Current Tax Liabilities (Net)
(d) Other Current Liabilities
Total Current Liabilities
Total Liabilities
TOTAL EQUITY AND LIABILITIES
Inventory In Days
Debtor in Days
Other Current Assets
Creditors in Days
Other Current Liabilities
STATEMENT OF CASH FLOWS for the year ended March 31, 2021
Particulars
A CASH FLOWS FROM OPERATING ACTIVITIES
Profit / (Loss) before tax
Adjustments for:
Depreciation and Amortisation expense
Depreciation Fund Written Back
Loss/(Profit) on sale of Property, Plant & Equipment (net)
Dividend Income
Interest Income
Finance Costs
Loss/(Profit) from Sale of Current Investments
Change in Fair value of the Current Investment
Provision for Doubtful Debts
Excess Provision/Credit Balance/Deposits written back
Excess Provision for Debtors
Scrap Sale of assets
Bad Debts Written off
Calculations
Total Borrowings
Depriciation
Capex
FCFF Calculation
EBIT(1-t)
Capex
Depriciation
Change in WC
Total Reinvestment
Year
FCFF
Terminal Value
PV of CF and terminal Value
Valuation
Terminal Growth rate
WACC
Value of Operating Assets
Value of Equity
# Shares Outstanding (lakhs)
Year Ended March 31, 2017 Year Ended March 31,Year Ended March 31, Year Ended March 3
51794.51 54585.94 57314.39 59150.57
0.053894322004398 0.049984483183765 0.03203698059074
187.58 309.37 284.2 258
51982.09 54895.363894322 57598.6399844832 59408.6020369806
Year Ended March 31, 2017 Year Ended March 31,Year Ended March 31, Year Ended March 3
1466.37395720142
Financial Statements
Year Ended March 3Year Ended March 31Year Ended MarchYear Ended March Year Ended March
34015.15 62928.0275 67962.2697 73399.251276 79271.19137808
-0.4249396075135 0.85 0.08 0.08 0.08
377.87 306.69 337.359 371.0949 408.20439
34392.5950603925 63235.5675 68299.7087 73770.426176 79679.47576808
53.72
-16.3
37.42
85.37
3.18
-0.8
2.38
87.75
9.9
9.9
Year Ended March 3Year Ended March 31Year Ended MarchYear Ended March Year Ended March
12.94
6.26
1421.62
321.2
638.81
8230.88
86.27
272.36
358.63
234.7
7.1
94.21
336.01
122.79
1327.35
48.36
-180.44
482.99
-9.39
-1.3
-
-147.24
-16.27
-50.2
2.09
1455.95
1578.74
-269.32
334.89
-154.08
-88.51
-14.85
1475.38
-398.68
340.56
9.39
181.9
133.17
157.19
-531.89
-847.11
-415.68
-
-1637.49
-28.94
67.81
38.87
1 2 3 4
2064.1184602593 2262.48471681 1698.031231543 1840.92649294
65991.5483699773
0.770813260978098
0.075
325.438306318125
0.13
1795.14622117391
0.215915068414952
14703.880746066
0.171748451837578
82816.0136435354
3245.97787379105
3571.41618010918
0.041715871503211
Year Ended March 31, 2026
9139.18232812542
3371.52257992335
3912.22037029209
38.87
54.5
9.45
20.14
1020.73049139036
8427.4334416058
240.38
7254.45480808046
8832.09
246.62
56.41
465.55
17095.5048080805
18.6479295011039
16.6792697967901
4.35175875699427
40.1244715475416
2.71476555712709
Year Ended March 31, 2026
2503.3715870625
1795.14622117391
2620.197283
2499.99132607642
2620.197283
1795.14622117391
928.305846014771
1753.35690784086
5 6
746.634418235566 794.493684444466
9084.18441148957
6445.33716920471
P/E ROE Beta
Vadilal Industries 12.7 18.21% 0.91
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.462617215144482
R Square 0.214014687748036
Adjusted R Square -0.100379437152749
Standard Error 12.7009652092785
Observations 8
ANOVA
df SS MS
Regression 2 219.620364 109.810182
Residual 5 806.572586 161.314517
Total 7 1026.19295
F Significance F
0.68072101 0.54769159
Fundamentals P/E
FRIESLANDCAMPINA ENGRO PAKIS 33.95
BEIJING SANYUAN FOODS CO-A 29.89
ZYDUS WELLNESS LTD 96.09
HERITAGE FOODS LTD 12.69
LANZHOU ZHUANGYUAN PASTURE-H 44.5
DUTCH LADY MILK INDS BHD 25.17
ZHEJIANG YIMING FOOD CO LT-A 40.11
HUBEI JUNEYAO GREAT HEALTH-A 31.14
NEW HOPE DAIRY CO LTD-A 38.86
FRASER & NEAVE HOLDINGS BHD 23.77
Mean 37.617
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.65958909344228
R Square 0.435057772188009
Adjusted R S 0.273645707098869
Standard Erro 6.76017542005204
Observations 10
ANOVA
df SS
Regression 2 246.35243803087
Residual 7 319.89980196913
Total 9 566.25224
Coefficients Standard Error
Intercept 40.1086880415046 7.38937124683613
Adj ROE -75.4247108578783 34.7212588131606
Beta 5.30360471050696 5.57065033208457
Comparables Approach
Calculated P/E 32.2253295364443
EPS (Forward looking) 65
Value Per share ₹ 2,094.65
No. of Shares 862668
Valuation ₹ 1,806,984,437.74
ROE Beta
14.46% 0.57
MS F Significance F
123.176219 2.69532375 0.13552335
45.6999717
t Stat P-value Lower 95% Upper 95% Lower 95.0% Upper 95.0%
5.42788915 0.00097882 22.6356016 57.5817745 22.6356016 57.5817745
-2.17229195 0.06639198 -157.527441 6.67801978 -157.527441 6.67801978
0.95206204 0.37277395 -7.86889016 18.4760996 -7.86889016 18.4760996